Peer Reviewed
This case report depicts a probable infusion reaction in a 61-year-old woman prescribed evinacumab for the treatment of familial hypercholesterolemia.
Jordan Krumanocker, PharmD, CPP, BCACP
Advertisement
Articles by Jordan Krumanocker, PharmD, CPP, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Outcomes of Older Patients on Enfortumab Vedotin for Urothelial Carcinoma
2
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence
3
Single-Center Experience With Vorasidenib in Patients With Grade 3 or 4 IDH-Mutant Gliomas
4
Are Non-Opioid Therapies Finally Challenging Opioids in Acute Pain Management?
5